You have 9 free searches left this month | for more free features.

PspA

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Active Peripheral Spondyloarthritis (pSpA) Trial (Secukinumab, Placebo)

Not yet recruiting
  • Active Peripheral Spondyloarthritis (pSpA)
  • Secukinumab
  • Placebo
  • (no location specified)
Mar 22, 2022

Pneumonia, Respiratory Tract Diseases, Respiratory Tract Infections Trial in Puer (PBPV, PPV23)

Not yet recruiting
  • Pneumonia
  • +2 more
  • PBPV
  • PPV23
  • Puer, Yunnan, China
    Lancang Lahu Autonomous County Center for Disease Control and Pr
Nov 10, 2022

Pneumonia, Respiratory Tract Diseases, Respiratory Tract Infections Trial in Shangqiu (Protein based pneumococcal vaccine(Low

Completed
  • Pneumonia
  • +2 more
  • Protein based pneumococcal vaccine(Low dose)
  • +5 more
  • Shangqiu, Henan, China
    Suixian Center for Disease Control and Prevention
Nov 3, 2022

Irritable Bowel Syndrome Trial in Pittsburgh (Mindfulness and Attention Training, Mindfulness training, Coping Condition)

Recruiting
  • Irritable Bowel Syndrome
  • Mindfulness and Attention Training
  • +2 more
  • Pittsburgh, Pennsylvania
    Carnegie Mellon University
Aug 16, 2022

Nasopharyngeal Carriage Study in Healthy Kenyan Toddlers

Completed
  • Pneumococcal Disease
    • Kisumu, Kenya
      Kenya Medical Research Institute/Walter Reed Project
    Feb 3, 2020

    Pneumonia, Pneumococcal Trial in Kisumu (PATH-wSP, Synflorix, Pentavac)

    Completed
    • Pneumonia, Pneumococcal
    • PATH-wSP
    • +3 more
    • Kisumu, Nyanza, Kenya
      Kenya Medical Research Institute/Walter Reed Project
    Oct 1, 2019

    Patients Older Than 75 Yrs Old Reaching End Stage Renal Disease

    Completed
    • Kidney Failure, Chronic
      • (no location specified)
      Sep 26, 2016

      Pneumonia Trial in St. Louis (Salmonella Typhi-vectored pneumonia vaccine)

      Completed
      • Pneumonia
      • Salmonella Typhi-vectored pneumonia vaccine
      • St. Louis, Missouri
        Saint Louis University Center for Vaccine Development
      Nov 1, 2011